BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

847 related articles for article (PubMed ID: 17145384)

  • 1. Gelatinase A activity in Dupuytren's disease.
    Augoff K; Ratajczak K; Gosk J; Tabola R; Rutowski R
    J Hand Surg Am; 2006 Dec; 31(10):1635-9. PubMed ID: 17145384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.
    Ulrich D; Ulrich F; Piatkowski A; Pallua N
    Arch Orthop Trauma Surg; 2009 Nov; 129(11):1453-9. PubMed ID: 18758795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D; Hrynyschyn K; Pallua N
    Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in the extracellular matrix proteoglycan profile in Dupuytren's contracture affect the palmar fascia.
    Koźma EM; Olczyk K; Wisowski G; Głowacki A; Bobiński R
    J Biochem; 2005 Apr; 137(4):463-76. PubMed ID: 15858170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dupuytren's palmar contracture in women.
    Stahl S; Calif E
    Isr Med Assoc J; 2008 Jun; 10(6):445-7. PubMed ID: 18669144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of MMP-2, TIMP-2, TGF-β1, and decorin in Dupuytren's contracture.
    Ratajczak-Wielgomas K; Gosk J; Rabczyński J; Augoff K; Podhorska-Okołów M; Gamian A; Rutowski R
    Connect Tissue Res; 2012; 53(6):469-77. PubMed ID: 22512703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
    Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
    J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase inhibition reduces contraction by dupuytren fibroblasts.
    Townley WA; Cambrey AD; Khaw PT; Grobbelaar AO
    J Hand Surg Am; 2008 Nov; 33(9):1608-16. PubMed ID: 18984345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor (EGF-R) in Dupuytren's disease.
    Augoff K; Taboła R; Kula J; Gosk J; Rutowski R
    J Hand Surg Br; 2005 Dec; 30(6):570-3. PubMed ID: 16055243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatan sulfate remodeling associated with advanced Dupuytren's contracture.
    Koźma EM; Głowacki A; Olczyk K; Ciecierska M
    Acta Biochim Pol; 2007; 54(4):821-30. PubMed ID: 18066404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Dupuytren's disease caused by an imbalance between proliferation and cell death?
    Jemec B; Grobbelaar AO; Wilson GD; Smith PJ; Sanders R; McGrouther DA
    J Hand Surg Br; 1999 Oct; 24(5):511-4. PubMed ID: 10597921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptors in Dupuytren's contracture.
    Pagnotta A; Specchia N; Greco F
    J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dupuytren's contracture as result of prolonged administration of phenobarbital.
    Tripoli M; Cordova A; Moschella F
    Eur Rev Med Pharmacol Sci; 2011 Mar; 15(3):299-302. PubMed ID: 21528776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
    J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An insight into Dupuytren's contracture.
    Murrell GA
    Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymes of glucose metabolism in palmar fascia and Dupuytren's contracture.
    Hoopes JE; Jabaley ME; Su CT; Wilgis S; Im MJ
    J Hand Surg Am; 1977 Jan; 2(1):62-5. PubMed ID: 190288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Dupuytren's disease of the palmar fascia.
    Rayan GM; Moore J
    J Hand Surg Br; 2005 Dec; 30(6):551-6. PubMed ID: 16203068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective review of the management of Dupuytren's nodules.
    Reilly RM; Stern PJ; Goldfarb CA
    J Hand Surg Am; 2005 Sep; 30(5):1014-8. PubMed ID: 16182060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dupuytren's contracture studied with monoclonal antibodies to connective tissue differentiation antigens.
    Bartal AH; Stahl S; Karev A; Lichtig C
    Clin Exp Immunol; 1987 May; 68(2):457-63. PubMed ID: 3308216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year follow-up.
    Watt AJ; Curtin CM; Hentz VR
    J Hand Surg Am; 2010 Apr; 35(4):534-9, 539.e1. PubMed ID: 20353858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.